En gennemgang af tabel XI-1 viser, at landene generelt anvender 12% af deres bevillinger til civil F & U til bioteknologi, dog er Irland og i mindre grad Grækenland undtaget.
Examination of Table XI-1 shows that countries generally devote 1 to 2% of their civil research appropriations to biotechnology R & D with the exception of Ireland and to a lesser extent Greece.